The present invention relates to bisarylurea derivatives of formula (I), the use of the compounds of formula (I) as inhibitors of raf-kinase, the use of the compounds of formula (I) for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.
[EN] SUBSTITUTED BISARYLUREA DERIVATIVES AS KINASE INHIBITORS<br/>[FR] DERIVES DE BISARYLUREE